Basel Medical Group Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Revenue Growth (YoY) Annually1,263.0%Target: Double-digit growth through clinic integration
Current Ratio Quarterly131.0%Target: Maintain above 1.20 for short-term liquidity
Debt-to-Equity Ratio Quarterly58.6%Target: Manage leverage below 60%
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Share price below $1.00Action: Execute the approved 1-for-12 reverse share split on June 22, 2026, to re-comply with Nasdaq Marketplace Rule 5550(a)(2).
- Integration of Bethesda Medical Pte. Ltd.Trigger: Operational disruptions or failure to realize cross-referral synergiesAction: Monitor outpatient and diagnostic imaging referral volumes and align clinical workflows.
- Nasdaq Periodic Filing ComplianceTrigger: Delinquency notifications due to incomplete audited financial statementsAction: Work with accounting, audit, and legal professionals to ensure timely and complete Form 20-F filings.
Research as of 20 Jun 2026